Navigation Links
PNAS Publishes Preclinical Results of EntreMed's 2ME2 for Multiple Sclerosis
Date:12/4/2012

tiated a dual-institutional Phase 2 study of ENMD-2076 in triple-negative breast cancer.  Its second compound, 2ME2, has been investigated in clinical trials in oncology patients, and is the subject of a successful IND filing for clinical use to treat RA.  Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission (the SEC).

Forward Looking Statements           

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance, strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed.

Actual results could differ materially from those currently anticipated due to a number of factors, including: the risk that we may be unable to continue as a going concern as a result of our inability to raise sufficient capital for our operational needs; the possibility that we may be delisted from trading on the Nasdaq Capital Market; the volatility of our common stock; the difficulty of executing our business strategy in China; our inability to enter into strategic partnerships for the development, commercialization, manufacturing and distribution of our proposed product candidate; risks relating to the need for additional capital and the uncertainty of securing additional funding on favorable terms; declines in actual sales of Thalomid® resulting in reduced royalty payments; risks associated with our product candidates; any early-stage products under development; results in precli
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
2. Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
3. Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics
4. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
5. American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
6. American Journal of Obstetrics and Gynecology Publishes PeriGen Research on Shoulder Dystocia
7. Pharmspective Publishes New Assessment of Impact of State Exchanges on Key Insurers and Pharma
8. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
9. Obesity journal publishes new study on lorcaserin, a weight-loss medication recommended for approval by FDA advisory panel
10. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
11. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...  The board of directors of VirtualScopics, Inc. (NASDAQ: ... trial imaging solutions, today announced that James Groff ... immediately.  Mr. Groff has held the role of acting ... in January 2006 as an accounting manager and was ... the board of VirtualScopics asked Jim to assume the ...
(Date:8/21/2014)... 21, 2014  SI-BONE, Inc. ( San Jose, ... the use of the iFuse Implant System, ® ... of the sacroiliac (SI) joint, announced that Priority Health ... its Lumbar Fusion Medical Policy No. 91590-R4 providing positive ... policy states that the fusion procedure, which employs the ...
(Date:8/20/2014)... 2014  The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful PSE sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 23,478 boxes of ...
Breaking Medicine Technology:VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 2011 As the Joint Select Committee on Deficit Reduction ... the next ten years, the Pharmaceutical Care Management Association ... committee opportunities to leverage greater use of pharmacy benefit management ... costs over that same time period. "Everyone in ...
... Aug. 31, 2011 LifeVantage Corporation (OTCBB: ... supplement, announced today that Douglas C. Robinson, the Company,s ... the Company,s Chief Science Officer, will be presenting at ... be held on September 11-13, 2011, at the Waldorf ...
Cached Medicine Technology:PCMA Outlines $100 Billion in Prescription Drug Savings for Deficit Reduction Committee 2PCMA Outlines $100 Billion in Prescription Drug Savings for Deficit Reduction Committee 3LifeVantage to Present at Rodman & Renshaw Annual Global Investment Conference 2
(Date:8/21/2014)... neuropathy is important for the successful treatment of ... Hospital of Kunming Medical University, China, led by ... index for nerve conduction studies in the early ... diabetes mellitus. Nerve conduction studies revealed that distal ... was slower, and sensory nerve action potential and ...
(Date:8/21/2014)... at the University of Montreal, the regions of the ... we train our bodies, movements and, critically, they interact ... knew that sleep helped us the learn sequences of ... subcortical regions are important in information consolidation, especially information ... is measured after a period of sleep, the brain ...
(Date:8/21/2014)... Rebecca Tabbert, owner of Calimesa Fit Body ... enjoyed watching as more people turn away from the ... camp environment. It’s not only good for her business; ... ‘treadmill-dumbbells-elliptical’ routine just doesn’t work,” she says. “Numerous research ... and lifting those cute little dumbbells does very little ...
(Date:8/21/2014)... Chicago, IL (PRWEB) August 21, 2014 ... EB-5 Business & Investment Exploratory Delegation to southern China ... unique opportunity to explore the rapid growing cities of ... each delegate will have the rare opportunity to meet ... their project(s) during a short weeklong time frame. ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Hunhu ... wellness solutions, announced today that it has entered into ... best practices, mobile technology and predictive analytics for recruiting, ... , According to Michael Emerson , co-founder ... for two patents on the technology used in what ...
Breaking Medicine News(10 mins):Health News:Learning to play the piano? Sleep on it! 2Health News:Calimesa Fit Body Boot Camp Announces Its Release of a New Video about the Fitness Boot Camp Experience 2Health News:Calimesa Fit Body Boot Camp Announces Its Release of a New Video about the Fitness Boot Camp Experience 3Health News:Artisan Business Group announces 2014 EB-5 Investment Trade Mission to China 2Health News:Hunhu Healthcare Enters into Licensing Agreement with Mayo Clinic 2
... to the Georgia Banker,s Insurance TrustATLANTA, March 3 ... of the Georgia Bankers Association Insurance Trust (GBAIT), ... Health, a health care data analytics company. ... cost and care management program that integrates wellness, ...
... Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased ... and Drug Administration (FDA) Level II Baseline Inspection and ... It is standard for the FDA to periodically perform ... inspection by the FDA validates the Company,s quality system ...
... a malabsorption syndrome conferring increased risk for various ... is significantly more frequent in patients with newly ... research team led by Dr. Muhammed Hadithi from ... and vitamin B12 daily supplements on homocysteine levels ...
... safe handling, packaging and administration of fluid medications, today announced ... robotics and software company. The ForHealth acquisition adds IntelliFill ... operations management. , ... Englewood, Colo. ...
... PALM BEACH GARDENS, Fla., March 3 Believing ... crucial especially with today,s financial crisis deepening, SilverCensus.com ... for caregivers, senior citizens, and healthcare professionals, announced ... to provide educational support for viewers seeking eldercare ...
... GenCircles, and Family Tree Legends to help ... founder of numerous genealogy companies and products, Cliff Shaw, recently ... "FamilyLink is charting new territory in family social networking ... of this. The growth the company is experiencing, even in ...
Cached Medicine News:Health News:Paragon Benefits, Inc. Selects North Star Health for Data Analysis and Cost Management Reporting 2Health News:Solos Endoscopy, Inc. Successfully Completes FDA Inspection 2Health News:Are vitamin supplements effective in celiac disease patients? 2Health News:Baxa Corporation Acquires Florida-Based ForHealth Technologies™ 2Health News:Baxa Corporation Acquires Florida-Based ForHealth Technologies™ 3Health News:SilverCensus.com Names Consumer Affairs Advocate, Healthcare Experts to Provide Free Educational Support for Seniors 2Health News:FamilyLink.com, Inc. Announces New Lead Developer 2Health News:FamilyLink.com, Inc. Announces New Lead Developer 3
... The Portex® Thermovent® T helps provide protection ... It is small and extremely lightweight making it ... adults. With a high rate of heat and ... secretion retention., ,All HMEs and filters have ...
circuitGuard™ Products are available in filter or filter/HME styles., ,High quality air cushion anesthesia masks may be packaged with any circuitGuard™ product....
... Since 1991 Intersurgical Incorporated ... filters, heat and moisture ... therapy products, hand-held nebulizers ... of accessories and connectors ...
... 1991 Intersurgical Incorporated manufactures ... heat and moisture exchangers, ... products, hand-held nebulizers and ... accessories and connectors for ...
Medicine Products: